Melbourne Clinical Trials

One in a Million Study

This study is looking at a medication for the treatment of Fibrodysplasia Ossificans Progressive (FOP), commonly known as Stone Man Syndrome. People with this condition live their lives in fear of minor injuries, which trigger the progression of their condition.

14 nights
3 visits

FOP, a rare disease which affects one in two million people, turns connective tissue such as tendons, muscles, and ligaments into bone. Currently there are no approved treatments for FOP, but there are medications to help control symptoms.

It is hoped that this study will lead to the development of new treatments for FOP. This study requires healthy participants to help us investigate how a healthy body metabolises the drug. The data acquired from this important research will then be used for further stages of testing.

This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.

Call us on 1800 243 733 to discuss your eligibility today!


Biological Sex Healthy males or post menopausal females
Age 18-50 (males), 45-50 (females)
BMI 18-32kg/m² (males), 18-32kg/m² (females)
Medication Not taking any (contraceptives ok)
Medical History Nothing significant
Smoking History Social smokers okay (less than 8 per week)